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The marker of alkyl DNA base 
damage, N7‑methylguanine, 
is associated with semen quality 
in men
B. Altakroni1,5, C. Nevin2, M. Carroll 2, C. Murgatroyd2, G. Horne3, D. R. Brison3,4 & 
A. C. Povey 1*
Sperm DNA contains a range of DNA base damage that can arise, in part, from exposure to 
methylating agents. However, the effects are not fully characterized and so the aim of this study 
was to investigate associations between semen quality and the levels of N7‑methyldeoxyguanosine 
(N7‑MedG), a marker of exposure to methylating agents, and other markers of DNA damage and DNA 
methylation. Sperm samples were collected from 105 men attending an assisted reproduction clinic as 
part of a couple undergoing treatment for infertility and semen quality assessed manually according 
to WHO guidelines. Semen levels of N7‑MedG, quantified by immunoslotblot, were significantly 
higher in men with sperm concentration < 15 × 106/ml (p ≤ 0.01), semen volume < 1.5 ml (p ≤ 0.05) and 
also in men with any aspect of semen quality below WHO reference levels (p ≤ 0.001). Measures of 
neutral Comet DNA damage were correlated with semen quality in a univariate analysis but not after 
adjustment for N7‑MedG levels. Sperm concentration was negatively associated with % methylation 
at the gene for DAZL but no other marker of global or gene‑specific DNA methylation. Results support 
the hypothesis that the known toxic and DNA damaging properties of alkylating agent exposure may 
have direct deleterious consequences on semen quality.
Sperm DNA contains damage that may impact on semen quality and ART  outcome1,2. This damage is not fully 
characterised, with the most widely used assays measuring some loss in DNA integrity such as single and/or 
double strand DNA breaks, DNA fragmentation or DNA  denaturation3. In addition, specific DNA base damage 
has also been detected in sperm DNA, particularly that arising from reactive oxygen species such as 8-oxogua-
nine4. However, other types of DNA base damage including that arising from methylating agents has also been 
 reported5. The potential adverse consequences of exposure to DNA methylating and other alkylating agents on 
somatic cells i.e. toxicity, mutagenicity and carcinogenicity is well  recognised6. Such changes are largely ascribed 
to DNA damage  formation7, though exposure to alkylating agents can induce other cellular changes including 
changes in gene  expression8 or histone  phosphorylation9. Treatment of male mice with the ethylating agent, 
N-ethyl-N-nitrosourea, causes mutations in sperm that has led to the development of many models of human 
 disease10,11. In contrast very little is known about DNA alkylation in human spermatozoa . We reported several 
years ago that N7-MedG levels, a biomarker of exposure to methylating  agents12, were associated with male factor 
infertility in a population of men attending as a part of a couple for ART 5. N7-MedG is quantitatively the most 
significant methyl DNA adduct, constituting around 70–85% of all adducts produced by methylating  agents13. 
Though N7-MedG does not alter DNA duplex structure or coding properties and is neither mutagenic nor  toxic14, 
N7-methylguanine in DNA is relatively unstable and can depurinate leading to abasic sites that are toxic and 
 mutagenic15 and can further lead to DNA strand  breaks16. More recently it has been reported that N7-MedG 
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adducts can form reversible, but toxic, DNA–protein cross links with histone  proteins17. Furthermore, overexpres-
sion of the DNA repair protein, N3-methylpurine-DNA glycosylase, that repairs this adduct, sensitises cells to 
the genotoxic effects of methylating  agents14,18. In addition, the presence of N7-MedG in DNA, depending upon 
the type of alkylating agent exposure, may also indicate significant levels of the pro-mutagenic, pro-carcinogenic 
and teratogenic adduct, O6-methylguanine19.
Associations between DNA alkylation and other types of DNA damage or DNA modifications, such as 
epigenetic methylation, in human sperm are unknown. To provide further information on these associations 
with semen quality, we have investigated these markers in sperm of men attending an infertility clinic as part 
of a couple.
Results
The study included 105 semen samples with data available for semen quality, DNA damage measured by Comet 
assay, and N7-MedG (101). Of these, 44 also had DNA methylation data.
Descriptive analysis of semen quality and markers of DNA damage and DNA methyla‑
tion. The semen quality of the studied population is shown in Table 1 together with a descriptive analysis of 
markers of DNA damage and DNA methylation. There were 28 men whose sperm concentration was less than 
15 × 106/ml, 18 men with a % progressively motility of < 32, and 11 men whose semen volume was less than 
1.5 ml. Overall there were 44 men with a below reference level of either sperm concentration, % progressive 
motility or semen volume.
% of sperm with low DNA damage (% LDD sperm) was inversely correlated  (rs = − 0.31, p < 0.001 n = 
105) with % of sperm with high DNA damage (% HDD sperm) and with median % tail DNA  (rs = -0.79, p < 0.001 
n = 105) whereas % HDD sperm was positively correlated with median % tail DNA  (rs = 0.67, p < 0.001 n = 105). 
N7-MedG in sperm DNA was negatively associated with % LDD sperm  (rs = -0.22, p < 0.05 n = 101) and posi-
tively associated with median % tail DNA  (rs = 0.20, p < 0.05 n = 101): it was not correlated with % HDD sperm 
 (rs = 0.12, n = 101). % DAZL methylation was positively associated with % HDD sperm  (rs = 0.37; p < 0.05) and 
with median % tail DNA  (rs = 0.39; p < 0.05). There was no other association between global methylation and 
gene-specific methylation or markers of DNA damage.
Relationship between semen quality and markers of DNA damage and DNA methyla‑
tion. Sperm concentration was negatively associated with N7-MedG levels  (rs = -0.32, p < 0.001), % HDD 
sperm  (rs = -0.41, p < 0.001), median % tail DNA  (rs = -0.31, p < 0.001) and with % methylation of DAZL  (rs = -0.56, 
p < 0.001) but not with global methylation or % methylation of H19CTCF6, SNRPN, or MEG3 (Table 2). The 
multiple regression model including N7-MedG, %HDD sperm, median % tail DNA and % DAZL was not sig-
nificant  (R2 = 0.20, p = 0.2) with DAZL methylation showing a non-significant trend (p = 0.08: Table 3).
% progressively motile sperm was positively associated with % LDD sperm  (rs = 0.34, p < 0.001), but negatively 
associated with % HDD sperm  (rs = -0.50, p < 0.001) and median % tail DNA  (rs = -0.48, p < 0.001). There was no 
other correlation between semen quality and global methylation or gene-specific DNA methylation (Table 2). 
The multiple regression model with % LDD sperm, % HDD sperm, median % tail DNA and N7-MedG produced 
 R2 = 0.28, (p < 0.001) with %HDD sperm (p < 0.01) and N7-MedG (p < 0.05) being significant (Table 3).
% immotile sperm was negatively associated with % LDD sperm  (rs = -0.31, p < 0.01), but positively associ-
ated with % HDD sperm  (rs = 0.41, p < 0.001) and median % tail DNA  (rs = 0.41, p < 0.001). There was no other 
correlation between semen quality and global methylation or % methylation of H19CTCF6, SNRPN, or MEG3 
(Table 2). The multiple regression model with %LDD sperm, % HDD sperm and median % tail DNA produced 
Table 1.  Descriptive analysis of semen quality and markers of DNA damage and DNA methylation.
Variable Value Mean ± SD (n) Range
Age Years 35.3 ± 5.8 (105) 26–57
Semen quality
Sperm concentration (× 106/ml) 59.1 ± 66.2 (105) 0.5–362.0
Progressive motile sperm (%) 49.0 ± 17.1 (105) 1.0–77.0
Immobile sperm (%) 40.9 ± 14.5 (105) 0.5–99.0
Semen volume (ml) 3.2 ± 1.4 (105) 0.5–8.1
Comet assay
Median tail DNA (%) 1.02 ± 0.76 (105) 0.07–5.28
Sperm with low DNA damage (LDD) (%) 15.4 ± 8.3 (105) 2.3–39.2
Sperm with high DNA damage (HDD) (%) 14.7 ± 8.6 (105) 4.0–47.2
N7-MedG fmoles/μg DNA 0.55 ± 0.35 (101) 0.12–2.30
Global methylation nM 396.1 ± 71.3 (44) 296–687
Gene Methylation
DAZL (% methylated) 4.6 ± 5.0 (31) 0.4–20.0
H19 (% methylated) 40.4 ± 11.9 (44) 12.8–73.0
MEG3 (% methylated) 77.4 ± 27.8 (45) 0–91.3
SNRPN (% methylated) 3.2 ± 2.5 (43) 0.7–12.3
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 R2 = 0.19, (p < 0.001) with %HDD sperm (p < 0.01), %LDD sperm (p < 0.01) and median % tail DNA (p < 0.05) 
all being significant (Table 3). Semen volume was not associated with any of the measured biomarkers.
Associations between semen quality and DNA damage and DNA methylation in men with 
semen quality above and below WHO referent values. To assess whether DNA damage and DNA 
methylation levels were associated with clinically more relevant factors, we examined whether levels were dif-
ferent in men whose semen quality was either below or above WHO reference values (Table 4). Specifically, 
N7-MedG levels, % HDD sperm and median % Tail DNA were higher in those men whose sperm concentration 
was < 15 × 106 ml. In contrast, % LDD sperm was lower and % HDD sperm and median %tail DNA higher, in 
men with < 32% progressively motile sperm. Furthermore, N7-MedG levels were higher in those men with a 
semen volume was less than 1.5 ml. Overall, in any men whose sperm concentration or % progressively motile 
sperm or semen volume was below the reference category, N7-MedG levels, % HDD sperm and median %tail 
DNA were significantly higher and % LDD sperm significantly lower compared to men whose semen quality was 
above the reference value. In this analysis there was no association between any DNA methylation marker and 
semen quality above or below the WHO reference value.
In a logistic regression analysis (Table 5), N7-MedG levels were significantly associated with low sperm 
concentration (OR 6.46, 95%CI 1.51–27.7) even after adjustment (OR 6.42, 95%CI 1.47–28.0) for other markers 
of DNA damage, % HDD sperm and median % tail DNA. Whilst % HDD sperm and % median tail DNA were 
significantly associated with having low progressive motility in a univariate analysis (Table 5), after adjustment 
Table 2.  Correlations between markers of DNA damage and methylation and semen quality. a rs Spearman 
rho correlation coefficient; *p < 0.05; ** p < 0.01; ***p ≤ 0.001; ‡ p = 0.053.





sperm (%) Immotile sperm (%) Semen volume (ml)
Alkylation N7-MedG (fmoles/μg DNA) -0.32*** (101) -0.19
‡ (101) 0.11 (101) -0.12 (101)
Integrity % sperm with low DNA damage (LDD) 0.11 (105) 0.34*** (105) -0.31** (105) 0.09 (105)
Integrity % sperm with high DNA damage (HDD) -0.41*** (105) -0.50*** (105) 0.41*** (105) 0.16 (105)
Integrity % tail DNA (median) -0.31*** (105) -0.48*** (105) 0.41*** (105) 0.04 (105)
Methylation
Global methylation 
(nM) 0.03 (44) 0.07 (44) -0.02 (44) 0.06 (44)
DAZL (% methylated) -0.56*** (31) -0.04 (31) 0.06 (31) 0.27 (31)
H19 (% methylated) -0.02 (44) -0.03 (44) 0.04 (44) -0.06 (44)
MEG3 (% methylated) 0.01 (45) 0.10 (45) -0.07 (45) 0.08 (45)
SNRPN (% methyl-
ated) -0.02 (43) 0.05 (43) -0.06 (43) -0.06 (43)
Table 3.  Multiple regression analysis of semen quality with DNA damage and DNA methylation markers. ‡ 
p < 0.1; * p < 0.05; **p < 0.01; ***p < 0.001.
Semen parameter Model variable B SE B β
Sperm concentration
Constant 132.5 42.4
DAZL -4.27 2.32 -0.33‡
N7MeG -45.86 74.91 -0.12
HDD -0.33 2.34 -0.04
Median tail 
DNA -12.44 26.91 -0.14
Progressive motility
Constant 62.80 6.84
N7MeG -7.83 3.86 -0.18*
HDD -0.79 0.30 -0.38**
Median tail 
DNA -1.56 4.96 -0.06
LDD 0.26 0.26 -0.14
Immotile sperm
Constant 45.6 5.21
HDD 0.93 0.26 0.55***
Median tail 
DNA -8.00 3.74 -0.42*
LDD -0.66 0.23 -0.38**
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for % LDD sperm and N7-MeG there were no significant associations. N7-MedG levels were associated with 
an increased risk of having low progressive motility but this increase was not significant  (ORadj 3.42, 95%CI 
0.89–13.2). N7-MedG levels were, however, significantly associated with having a semen sample with any param-
eter below the WHO reference value (OR 20.7, 95%CI 2.75–155.6) and after adjustment with other markers of 
DNA damage (OR 19.0, 95%CI 2.41–150). No markers of DNA damage were associated with poor semen quality 
after adjustment.
Discussion
In this study of sperm DNA damage and DNA methylation of men attending for ART as part of a couple, the 
main finding was that N7-MedG levels were significantly associated with adverse semen quality even after adjust-
ment for other markers of DNA damage as measured by the Comet assay. Measures of DNA damage assessed by 
the Comet assay were correlated with % progressive motility and % immotile sperm and differed in men whose 
semen quality was below WHO reference levels in a univariate analysis but not after adjustment for N7-MedG 
levels. Sperm concentration was negatively associated with % methylation of DAZL but no other marker of DNA 
methylation was associated with adverse semen quality in this study.
N7-MedG is a marker of exposure to exogenous and endogenous DNA methylating agents and has been 
detected in a wide range of human  tissues13. The precise contribution of exogenous (e.g. tobacco specific nitrosa-
mines) and endogenous (e.g. s-adenosylmethionine and other agents formed in situ through N-nitrosation of 
amines) methylating agents to N7-MedG levels is unknown. Smoking is an exclusion criterion for treatment in 
our NHS centre and none of the men in the study were self-reported current smokers making it very unlikely 
that smoking was associated with N7-MedG levels.
There is also evidence that obesity is associated with DNA damage levels in that higher levels of DNA frag-
mentation (ie cells that did not have a detectable nucleus but only a Comet tail as detected by the alkaline Comet 
assay) were reported in obese men as compare to  controls20,21. However, we found no correlation between BMI 
and DNA damage levels (data not shown). However, the finding in this study that N7-MedG levels were signifi-
cantly associated with adverse semen quality is consistent with our previous report that N7-MedG levels were 
higher in men diagnosed with male factor  infertility5 and implicates DNA base damage, and not just DNA strand 
breaks, as a contributing cause of male infertility. The mechanistic basis of this association is unclear but it might 
be related to the known chemical instability of the N7-MedG adduct leading to DNA strand  breaks16 and it is 
worthy of note that N7-MedG levels were negatively associated with %LDD sperm and positively associated with 
Table 4.  Associations between markers of DNA damage and semen quality categorised by WHO reference 
values. a % sperm with low DNA  damage; b % sperm with high DNA damage; Statistically significant by Mann 
Whitney U test: ‡ p ≤ 0.1; * p ≤ 0.05;** p ≤ 0.01; *** p ≤ 0.001.
Semen variable Category
Marker of DNA damage or methylation. Mean ± SD (n)
N7-MedG % LDD  sperma % HDD  spermb % Tail DNA
Concentration
 > 15 × 106/ml 0.49 ± 0.29 (77) 16.2 ± 8.7 (77) 13.4 ± 8.2 (77) 0.88 ± 0.62 (77)
 < 15 × 106/ml 0.75 ± 0.47 (24)** 13.3 ± 7.1 (28) 18.1 ± 8.9 (28)** 1.39 ± 0.97 (28)***
Progressive motility
 > 32% 0.53 ± 0.33 (86) 16.3 ± 8.5 (87) 13.0 ± 6.9 (87) 0.87 ± 0.54 (87)
 < 32% 0.70 ± 0.46 (15)‡ 11.0 ± 6.1 (18)* 22.7 ± 11.3 (18)*** 1.74 ± 1.16 (18)***
Semen volume
 > 1.5 ml 0.51 ± 0.28 (91) 15.6 ± 8.5 (94) 14.6 ± 8.7 (94) 1.02 ± 0.79 (94)
 < 1.5 ml 0.91 ± 0.69 (10)* 13.6 ± 6.8 (11) 15.8 ± 7.9 (11) 1.03 ± 0.44 (11)
Any category
 > Reference 0.45 ± 0.20 (61) 17.3 ± 8.9 (61) 12.2 ± 7.2 (61) 0.77 ± 0.53 (61)
 < Reference 0.71 ± 0.47 (40)*** 12.9 ± 6.8 (44)* 18.1 ± 9.2 (44)*** 1.36 ± 0.89 (44)***
Table 5.  Unadjusted and  adjusteda associations between DNA damage marker and poor semen quality 
categorised by WHO reference values. a Adjusted for other markers of DNA damage that were significantly 





Semen volume Concentration Progressive motility Any category
Unadjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
N7MedG 7.2 (1.7–30.0) 6.46 (1.51–27.7) 6.42 (1.47–28.0) 2.80 (0.79–9.91) 3.42 (0.89–13.2) 20.7 (2.75–155.6) 19.0 (2.41–150)
% LDD  spermb - - - 0.91 (0.84–0.98) 0.98 (0.87–1.10) 0.93 (0.88–0.98) 1.03 (0.94–1.13)
% HDD  spermc - 1.06 (1.01–1.12) 0.99 (0.90–1.08) 1.12 (1.05–1.20) 1.09 (0.97–1.22) 1.10 (1.04–1.17) 1.01 (0.92–1.12)
% Tail DNA - 2.48 (1.26–4.86) 2.33 (0.75–7.31) 4.54 (1.89–10.9) 1.54 (0.23–10.2) 4.90 (2.03–11.8) 5.17 (0.8–33.2)
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median % tail DNA. In this context N7-MedG instability might represent a previously uncharacterised exposure 
route to increased DNA strand breaks in human sperm. Alternatively, the association between N7-MedG and 
adverse semen quality may be due to toxic DNA protein cross-links17 or due to the presence of other more toxic 
adducts such as O6-methylguanine or N3-methyladenine that will be formed at the same time as N7-MedG22. 
The latter 2 adducts have as far as we can ascertain not yet been reported in human sperm DNA but their pres-
ence in sperm DNA may have more deleterious consequences as O6-methylguanine is a known pro-mutagenic 
 adduct19 and N3-methyladenine can induce chromosome  aberrations23. The post-fertilisation effects of these 
adducts would depend not only on its levels in individual sperm but also the repair capacity of the oocyte.
The Comet assay measures a variety of different types of DNA damage (e.g. single and double strand breaks 
and apurinic sites) whether induced for example, by oxidative stress, chemical modifications of DNA or DNA 
repair  processes24,25. The precise contribution of these different mechanisms to DNA damage in any one sample 
is unknown. The neutral Comet assay has been reported to measure principally double-strand breaks as Alu1 
induced DNA fragmentation was higher with the neutral Comet assay than the alkaline comet  assay26. This, 
though, is controversial with other authors reporting that the neutral comet assay measures single strand nicks 
when the DNA remains attached to the nuclear  matrix27. As the extent of strand breaks increases, very large 
stretches of DNA can become detached from the matrix and move out of the nucleus and into the  gel28. We refer 
to these events as DNA damage, recognising that the neutral Comet assay measures a mix of single and double 
strand breaks. The relationship between DNA damage detected by the neutral Comet assay and semen quality 
is currently unclear. The DNA fragmentation index in sperm, as assessed by the neutral Comet assay, has been 
negatively associated with sperm concentration and morphology in one  study1, and with sperm viability, motil-
ity and morphology but not sperm  concentration29. Similarly, a weak correlation was observed between tail % 
intensity and % motility, % normal morphology but not sperm  concentration30. Conversely, no associations 
between semen quality and % tail DNA were detected in 80 healthy male  volunteers31. It is unclear whether 
these differences result from differences in analysis protocols, descriptors of DNA damage or populations stud-
ied, though in one study associations between indices of semen quality varied with how the DNA damage was 
 characterised32. One additional interpretation is that the differences in associations may result from differences 
in other types of DNA damage e.g. N7-MedG present within human sperm.
Previous studies have reported associations between environmental exposures and/or DNA damage and 
sperm DNA methylation in specific genes, suggesting, at least, that DNA damage and DNA methylation share 
a common exposure or cause and potentially that the effects of such exposure are mediated, in part, by their 
epigenetic effects. Associations between reactive oxygen species and H19-IgF2 methylation have been  described33 
and also methylation levels of IGF2 and KCNQ1 but not H19, MEG3, PEG3, SNRPN were associated with DNA 
fragmentation  index34. We also examined but found no associations between markers of DNA damage and global 
DNA methylation and methylation of genes that have been previously associated with male  infertility35. This 
suggests that the effects of alkylating agent exposure may not be mediated through changes in DNA methylation, 
but rather via the direct effects of DNA damage. The exact source/origin of DNA damage detected by the Comet 
assay still remains unknown but there is little evidence in the present study of these sources also impacting on 
the methylation of sperm. If such associations do exist, they will likely depend upon the initial exposures caus-
ing the DNA damage. DAZL methylation was negatively associated with sperm concentration, consistent with 
previous  studies36. Higher DAZL methylation was found in asthenozoospermia and oligozoospermia  men37. 
In contrast, no associations were detected with global methylation or methylation of other genes (H19, MEG3, 
NR3C1, SNRPN) that have previously been associated with semen  quality35; this may be due to population or 
sample size differences.
Like previous studies examining associations between DNA damage and semen quality, the main weakness 
of this study is that it is cross-sectional in nature and so unable to determine causative associations between the 
measured biomarkers and semen quality. In addition, there is the possibility that the levels of N7-MedG reported 
here may reflect levels occurring in contaminating leucocytes and round cells (for example). However, as these 
samples were used for clinical purposes, numbers of other cells were routinely assessed and samples identified as 
containing high levels of leucocytes and round cells were omitted from the study. Furthermore, seminal round 
cells have been reported to be mostly immature post-meiotic germ  cells38 and leucocytes account for maximum 
5% of total number of round cells in the seminal  fluid39. The alternative possibility that low levels of leucocytes 
and round cells influenced the results is considered unlikely as their N7-MedG levels would have had to have 
been much higher than observed here , at levels only previously observed in patients receiving methylating 
agent  chemotherapy13. We are thus confident that the results herein are representative of sperm N7-MedG levels.
However, our results are consistent with current knowledge regarding the toxicological consequences of 
alkylating agent exposure in other tissues. This study and other studies indicate that sperm DNA contains a 
range of different types of DNA damage that might be associated with semen quality and have more deleterious 
consequences post-fertilisation.
Materials and methods
Study population and ethical approval. 105 men of couples attending the Department of Reproductive 
Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, for assisted reproduc-
tion treatment (ART), participated in this study. All couples had provided written informed consent for research 
and this study had Local Ethics Committee Approval (Central Manchester REC ERP/91/078, HFEA research 
licence R0026) and was performed in accordance with relevant guidelines/regulations.
Semen analysis. Participants provided by masturbation a semen sample on the day of ART treatment. 
After liquefaction, semen volume, sperm concentration and motility were determined manually according to 
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WHO  guidelines40 in the hospital by biomedical and clinical scientific staff, and according to the UK NEQAS 
Reproductive Sciences  scheme41. Samples were to be used for clinical treatment and those with any significant 
round cell/white blood cell count or samples with leukospermia were omitted from the study. After collecting 
the remaining sample from the hospital, the neat semen was centrifuged to separate the sperm from the seminal 
plasma and an aliquot of the neat sperm pellet was directly used to determine the level of DNA damage by using 
the neutral Comet assay.
Extraction of DNA from sperm. Briefly, genomic DNA was extracted from up to 4 × 107 sperm cells using 
the Qiagen Blood and cell culture DNA Midi Kit except that the proteinase K and ribonuclease A digestion step 
was carried out at 4 °C overnight. The following day, 0.5 ml of 5 mM DTT solution was added to each tube, 
mixed and incubated again in the cold room on a rotor mixer for 1 h, followed by incubation for another 1 h 
at 37˚C in water bath. Following the manufacturer’s instructions, the samples were added into gravity flow col-
umns. Eluted from the columns, DNA was isopropanol and ethanol precipitated and rapidly air dried to remove 
residual alcohol. The concentration of extracted sperm DNA in 1X TE buffer was measured first by Nano-drop 
and then by a picogreen  assay5.
N7‑MedG slotblot analysis of sperm DNA. Immunoslotblot analysis of N7-MedG in sperm DNA has 
been described  previously5,12. Methylated DNA standards were prepared by reacting CT-DNA with N-nitroso-
N-methylurea. Briefly, DNA samples were sonicated (Sonicator, Bandeline electronic sonopuls, UW 2070, 
Probe: SH70G) for 10 s at 50% power to obtain DNA fragments of size between 400 and 1500 bp and these were 
incubated in alkaline solution to induce imidazole ring opening. After neutralisation, DNA samples were heat 
denatured and then 1 µg of DNA immobilised on a nitrocellulose membrane (Whatman: Portran, BA79, pore 
size 0.1  µm). Membranes were incubated first with a rabbit polyclonal antibody raised against 2,6-diamino-
4-hydroxy-5-N-methylformamidopyrimidine (me-Fapy) conjugated to keyhole limpet hemocyanin which spe-
cifically detected N7-MedG in mice treated with N-Nitroso-N-methylurea42 and then a polyclonal goat anti-
rabbit-horseradish peroxidase conjugate. Membranes were incubated with ECL reagent (Amersham Hyperfilm) 
and exposed to an X-ray film (Fuji) which was subsequently developed and scanned using a HP Scanjet 485. The 
intensity of the bands for the samples and the standards was quantified by using ImageJ program and a standard 
curve was generated and subsequently the levels of N7-MedG in the samples were calculated. To confirm DNA 
binding the membrane was stained with a propidium iodide solution and scanned with a Typhoon scanner (GE 
Healthcare) at 610 emission and 560 absorption wavelengths and the intensity of DNA bands in the obtained 
image quantified using ImageJ.
Single‑cell gel electrophoresis (Comet) assay. DNA damage was assessed by a neutral comet assay 
according to previous studies but with minor  modifications1,43. Sperm (~ 2 × 104) were suspended in LMP 
agarose and applied to a microscope slide pre-coated with 1% NMP agarose. After gel setting, the slides were 
immersed firstly in freshly made precooled lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM Tris-base, 10% 
DMSO and 1% Triton X-100, pH 10) at 4 °C, then in fresh lysis buffer containing 10 mM DTT and finally fresh 
lysis buffer containing proteinase K (100 μg/ml) to lyse the cells. The slides were then equilibrated for 20 min in 
cold electrophoresis buffer (300 mM sodium acetate 100 mM Tris, pH9) then electrophoresis was carried out 
at 13 V, 120–125 mA for 1 h. After neutralisation in cold neutralization buffer (0.4 M Tris-base pH 7.5), slides 
were stained with SYBR gold (Invitrogen, UK) used according to the manufacturer’s instructions and were then 
examined using an Olympus fluorescence microscope (OLYMPUS, U-RFL-T; Filter: FITC; Camera: Q IMAG-
ING, RETIGA-SRV, FAST 1394; Software: QCapture Pro 6.0) and around 35 images containing in total around 
400 sperm (Comet) were obtained. Then, % tail DNA was determined by using TriTeK CometScoreTM Freeware 
version 1.5 (TriTeK Corp, US) in 400 sperm.
Prior to the analysis of the participant samples, we validated our neutral comet assay by incubating sperm with 
up to 30 µM  H2O2 and this clearly showed that the assay was able to detect increases in DNA damage induced 
by a DNA damaging agent. We found a dose-dependent decrease in the % of sperm with few strand breaks 
 (r2 = 0.077: < 2% at the highest  H2O2 concentration ) and a dose-dependent increase in median levels of % tail 
DNA  (r2 = 0.91) and % sperm with high levels of DNA damage  (r2 = 0.90: 20% at the highest  H2O2 concentration). 
A pilot reproducibility study also showed little variance from day to day.
Global DNA methylation. Genomic DNA was heat-denatured and digested to nucleosides by nuclease P1 
(Sigma, UK) and then alkaline phosphatase (Sigma, UK). 5-methylcytosine levels were then quantified using the 
Global DNA Methylation ELISA Kit (Cambridge Biosciences, UK), following the manufacturer’s instructions.
Gene specific methylation. DNA samples underwent bisulphite conversion using the EpiTect Fast DNA 
Bisulphite Kit (Qiagen, UK), according to the manufacturer’s instructions. Pyrosequencing target regions were 
amplified using the PyroMark PCR Kit (Qiagen, UK) as follows: PCR reactions were performed in a total vol-
ume of 25 μl consisting of 12.5 μl 2 × PCR master mix, 2.5 μl 10 × CoralLoad, 0.75 μl (3 μM) of each forward 
and reverse primer, 2  μl (~ 10  ng) bisulfite-converted DNA and 6.5  μλ  H2O. Primer sequences covering the 
target CpG regions were either purchased as pre-designed CpG assays from Qiagen UK (Supplementary data 
Table 1), or custom oligonucleotides were designed using the PyroMark Assay Design software (Qiagen, UK) 
and purchased through Life Technologies (UK) (Supplementary Table 2). Gradient PCR was initially carried 
out to determine the optimal annealing temperature for amplification ranging from 52 to 60  °C and cycling 
conditions were carried out as follows: 95 °C for 15 min; followed by 45 cycles of denaturation, 94 °C for 30 s; 
annealing, 56 °C for 30 s; extension, 72 °C for 30 s. Finally, an extension of 72 °C for 10 min was included. PCR 
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products were frozen at -20 °C until pyrosequencing. PCR products were immobilised to Streptavidin Sepharose 
High Performance beads (GE Healthcare Life Sciences, Uppsala, Sweden), denatured and the pyrosequencing 
primer (Supplementary Table) was annealed to the template. Pyrosequencing was performed on a PyroMark 
24 Pyrosequencing system (Qiagen). Results were analysed on the PyroMark Q24 software to determine the % 
methylation for each CpG site.
Statistical analyses. Semen quality was assessed both as a continuous variable and after dividing the popu-
lation into two based upon WHO reference values for semen  quality44 (i.e. sperm concentration > 15 × 106/ml, 
% progressive motility > 32% and a semen volume > 1.5 ml). We established the Comet thresholds blind to the 
semen quality status. The distribution of % tail DNA in the sperm samples was not normal with the log % tail 
DNA showed an almost trimodal distribution in 75% of the samples, ~ 14% of the samples showed biomodal 
distributions while the remaining 11% samples showed multimodal distribution. It was possible to distinguish 
two subgroups of sperm; sperm with low levels of DNA damage (% tail DNA < 0.005%, LDD sperm) and sperm 
with high levels of DNA damage (% tail DNA ≥ 7.5%, HDD sperm). Correlation (Spearmann rank analysis) 
and multiple regression analyses (including those markers whose associations with semen quality had a p ≤ 0.1) 
were conducted to examine the relationship between semen quality and markers of DNA damage and DNA 
methylation (mean methylation of all CpG sites analysed). This regression analysis is of limited clinical value 
and so biomarker levels were then compared in men whose semen quality were above or below WHO referent 
levels in both a univariate analysis and by logistic regression after adjustment for other DNA damage markers 
with P < 0.1.
Data availability
The datasets generated during and analysed during the current study are available from the corresponding author 
on reasonable request.
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